India — National Geophysical Research Institute & Moderna

India — National Geophysical Research Institute: The India — National Geophysical Research Institute in Kinshasa conducted laboratory tests that confirmed the Bundibugyo ebolavirus strain in the Ebola outbreak, playing a crucial role in identifying the specific variant.

Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

India — National Geophysical Research Institute: The India — National Geophysical Research Institute>>> is involved in the medical response to the Ebola outbreak, with its medical director confirming cases.

Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.

India — National Geophysical Research Institute: The India — National Geophysical Research Institute>>> is involved in the medical response to the Ebola outbreak, with its medical director confirming cases.

Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.